Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen R Kelly

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
The American Journal of Gastroenterology|October 18, 2021
Correction to: ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile InfectionsColleen R Kelly, Monika Fischer, Jessica R Allegretti, et al.
Gastroenterology|February 23, 2024
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal DiseasesAnne F Peery, Colleen R Kelly, Dina Kao, et al.
Nutrients|January 28, 2026
A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal DiscomfortJessica R Allegretti, Zain Kassam, Colleen R Kelly, et al.
Nutrients|September 13, 2025
Multi-Species Synbiotic Supplementation Enhances Gut Microbial Diversity, Increases Urolithin A and Butyrate Production, and Reduces Inflammation in Healthy Adults: A Randomized, Placebo-Controlled TrialBrooke A Napier, Jessica R Allegretti, Paul Feuerstadt, et al.
Cancer Research|February 5, 2003
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in miceMin Yao, Stacia Kargman, Eugene C Lam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2022
Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionByron P Vaughn, Monika Fischer, Colleen R Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 11, 2020
Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota TransplantationGhadeer K Dawwas, Colleen M Brensinger, Ravy K Vajravelu, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Multi-Species Synbiotic Supplementation After Antibiotics Promotes Recovery of Microbial Diversity and Function, and Increases Gut Barrier Integrity: A Randomized, Placebo-Controlled TrialBrooke A Napier, Jessica R Allegretti, Paul Feuerstadt, et al.
Journal of Clinical Gastroenterology|February 4, 2020
Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile InfectionBryce K Perler, Brendan Chen, Emmalee Phelps, et al.
Gut Microbes|June 20, 2020
Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantationJessica R Allegretti, Ryan J Elliott, Alim Ladha, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
The American Journal of Gastroenterology|October 18, 2021
Correction to: ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile InfectionsColleen R Kelly, Monika Fischer, Jessica R Allegretti, et al.
Gastroenterology|February 23, 2024
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal DiseasesAnne F Peery, Colleen R Kelly, Dina Kao, et al.
Nutrients|January 28, 2026
A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal DiscomfortJessica R Allegretti, Zain Kassam, Colleen R Kelly, et al.
Nutrients|September 13, 2025
Multi-Species Synbiotic Supplementation Enhances Gut Microbial Diversity, Increases Urolithin A and Butyrate Production, and Reduces Inflammation in Healthy Adults: A Randomized, Placebo-Controlled TrialBrooke A Napier, Jessica R Allegretti, Paul Feuerstadt, et al.
Cancer Research|February 5, 2003
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in miceMin Yao, Stacia Kargman, Eugene C Lam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2022
Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionByron P Vaughn, Monika Fischer, Colleen R Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 11, 2020
Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota TransplantationGhadeer K Dawwas, Colleen M Brensinger, Ravy K Vajravelu, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Multi-Species Synbiotic Supplementation After Antibiotics Promotes Recovery of Microbial Diversity and Function, and Increases Gut Barrier Integrity: A Randomized, Placebo-Controlled TrialBrooke A Napier, Jessica R Allegretti, Paul Feuerstadt, et al.
Journal of Clinical Gastroenterology|February 4, 2020
Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile InfectionBryce K Perler, Brendan Chen, Emmalee Phelps, et al.
Gut Microbes|June 20, 2020
Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantationJessica R Allegretti, Ryan J Elliott, Alim Ladha, et al.
Pageof 9